How BioPort (with Ivin's help) Grabbed a a Billion Dollar Monopoly on Anthrax Vaccine
There's an important, unnoticed backstory in the death of Bruce Ivins, the biotoxins scientist who is now blaimed for the anthrax attacks that followed 9/11.
Can’t go into all the details here, but Ivins was involved in anthrax vaccine development for three companies, Bioport/Emergent, Coley, and VaxGen. There seems to have been a recent struggle between two of them, BioPort/Emergent and VexGen, for a lion's share of $5.6 billion in federal biodefense contracts. The third company, Coley, licensed its vaccine additive to the losing company, VaxGen, in March 2007.
Vaxgen lost its federal contract later in 2007, and in May 2008 was bought out by Emergent.
That leaves BioPort/Emergent the sole approved provider of anthrax vaccine. There are some vexing historical details about BioPort that I won’t go into here that you should be aware of. If you're not, see, http://whatreallyhappened.com/... ; http://www.freepress.org/... .
MORE below
